OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves adjusting various factors, including cell line selection, media ingredients, and bioreactor settings. A key goal is to increase antibody titer while reducing production expenses and